UNITED ~~STATES~~STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of ~~the~~Report ~~Securities~~(Date ~~Exchange~~of ~~Act~~earliest ofevent ~~1934~~reported): March 27, 2025

Date of Report (Date of earliest event reported): March 11, 2025

THIRD HARMONIC BIO, INC.

(Exact name of ~~registrant~~Registrant as ~~specified~~Specified in ~~its~~Its ~~charter~~Charter)

Delaware	~~001-41498~~	001-41498	83-4553503
(State or other jurisdictionof incorporation)	(CommissionFile Number)		(IRS EmployerIdentification No.)
(State or Other Jurisdictionof Incorporation)		(Commission File Number)	(IRS EmployerIdentification No.)
1700 Montgomery Street, Suite 210
San Francisco, California			94111
(Address of Principal Executive Offices)			(Zip Code)

1700 Montgomery Street, Suite 210San Francisco, California		94111
(Address of principal executive offices)		(Zip Code)

    Registrant’s Telephone Number, Including Area Code: (209) 727-2457

   

(209) 727-2457

(Registrant’s telephone number, including area code)

N/A

(Former ~~name~~Name or ~~former~~Former ~~address~~Address, if ~~changed~~Changed ~~since~~Since ~~last~~Last ~~report~~Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		~~Trading symbol~~TradingSymbol(s)		Name of each ~~exchangeon~~exchange on which registered
Common Stock, par value $0.0001 per share		THRD		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 72.~~01.~~02 ~~Regulation~~Results FDof ~~Disclosure~~Operations and Financial Condition.

On March 27, 2025, Third Harmonic Bio, Inc. (the “Company”) isissued ~~furnishing~~a ~~its~~press ~~corporate~~release ~~presentation,~~reporting ~~which~~the itCompany’s ~~intends~~financial toresults ~~use~~for inthe ~~conferences~~fourth quarter and ~~meetings.~~full ~~The~~year ~~full~~ended December 31, 2024. A copy of the Company’s ~~corporate~~press ~~presentation~~release is ~~filed~~attached as Exhibit 99.1 ~~hereto.~~to ~~The~~this ~~corporate presentation will also be available on the Company’s website in the Investors & Media section at https://ir~~report.~~thirdharmonicbio.com.~~

The information ~~furnished~~ in this Item 2.02, including Exhibit 99.1 attached to this report, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, ~~nor~~as amended (the “Securities Act”). The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall itnot be ~~deemed~~ incorporated by reference into any other filing under the ~~Securities~~Exchange Act ~~of 1934, as amended,~~ or under the ~~Exchange~~Securities Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) ~~Exhibits~~ Exhibits.

ExhibitNo.		Description
ExhibitNumber		Description
99.1		~~Corporate~~Press ~~Presentation~~Release issued by Third Harmonic Bio, Inc. dated March 27, 2025
104		Cover Page Interactive Data File (~~formatted~~embedded aswithin the Inline XBRL document).

~~SIGNATURE~~ SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THIRD HARMONIC BIO, INC.

~~THIRD HARMONIC BIO, INC.~~

Date: March 11, 2025

/s/ Chris Murphy

March 27, 2025

/s/ Christopher Murphy

Chris Murphy

Christopher MurphyChief Financial and Business Officer

Chief Financial and Business Officer

Filing Compare · Third Harmonic Bio, Inc.